Biotech · Private company · Los Angeles, CA, US

Paralos Bioscience Inc.

Track this companyFree. Adds Paralos Bioscience Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards1

Development of a safer, more effective formulation of Polymyxin B for treatment of E. coli InfectionFiscal year 2026 · $306.5KNIH RePORTER 1R43AI191983-01A1 · fetched Nov 12, 2026